Chest Dynamic MRI as Early Biomarker of Respiratory Impairment in Amyotrophic Lateral Sclerosis Patients: A Pilot Study
Authors:
- Francesco BarbatoFBFrancesco Barbato
- Alessandro BombaciABAlessandro Bombaci
- Giovanni ColaciccoGCGiovanni Colacicco
- Giorgia BrunoGBGiorgia Bruno
- Domenico IppolitoDIDomenico Ippolito
- Vincenzo PotaVincenzo Pota
- Salvatore DongiovanniSDSalvatore Dongiovanni
- Giacomo SicaGiacomo Sica
- Giorgio BocchiniGBGiorgio Bocchini
- Tullio ValenteTVTullio Valente
- Mariano ScaglioneMariano Scaglione
- Pier Paolo MainentiPMPier Paolo Mainenti
Open Access
- 25 May 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3103
Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a neuromuscular progressive disorder characterized by limb and bulbar muscle wasting and weakness. A total of 30% of patients present a bulbar onset, while 70% have a spinal outbreak. Respiratory involvement represents one of the worst prognostic factors, and its early identification is fundamental for the early starting of non-invasive ventilation and for the stratification of patients. Due to the lack of biomarkers of early respiratory impairment, we aimed to evaluate the role of chest dynamic MRI in ALS patients. Methods: We enrolled 15 ALS patients and 11 healthy controls. We assessed the revised ALS functional rating scale, spirometry, and chest dynamic MRI. Data were analyzed by using the Mann–Whitney U test and Cox regression analysis. Results: We observed a statistically significant difference in both respiratory parameters and pulmonary measurements at MRI between ALS patients and healthy controls. Moreover, we found a close relationship between pulmonary measurements at MRI and respiratory parameters, which was statistically significant after multivariate analysis. A sub-group analysis including ALS patients without respiratory symptoms and with normal spirometry values revealed the superiority of chest dynamic MRI measurements in detecting signs of early respiratory impairment. Conclusions: Our data suggest the usefulness of chest dynamic MRI, a fast and economically affordable examination, in the evaluation of early respiratory impairment in ALS patients.Keywords
This publication has 24 references indexed in Scilit:
- Characterizing Expiratory Respiratory Muscle Degeneration in Duchenne Muscular Dystrophy Using MRIChest, 2022
- Neuromuscular diseases in the pandemic age: 6 months of experience of a newborn clinical centerNeurological Sciences, 2022
- Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?Neurological Sciences, 2021
- Imaging respiratory muscle quality and function in Duchenne muscular dystrophyJournal of Neurology, 2019
- Diaphragm Involvement in Duchenne Muscular Dystrophy (DMD): An MRI StudyJournal of Magnetic Resonance Imaging, 2019
- Assessing Diaphragm Function in Chest Wall and Neuromuscular DiseasesClinics in Chest Medicine, 2018
- Diaphragm Dysfunction in Critical IllnessChest, 2018
- Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophyAnnals of Clinical and Translational Neurology, 2017
- Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessmentNeuromuscular Disorders, 2015
- Neuromuscular ultrasound for evaluation of the diaphragmMuscle & Nerve, 2012